In a study conducted by Pavik et al. [20] on eighty-seven CKD patients in different stages, it was reported that while the PTH and P levels increased in the later stages of CKD, the plasma sKl levels firstly decreased then FGF23 increased and 1,25(OH)2D3 decreased. The gene discussed is FGF23; the disease is chronic kidney disease.